September 22, 2014: Accinov, the biomanufacturing center of Lyonbiopole, obtains the authorization to open a pharmaceutical site from the French Health authority (ANSM)

Lyonbiopole announces that the French Health authority (ANSM) delivered to Accinov, its Innovation Centre, the authorization to open a pharmaceutical site. This authorization will allow Accinov to support the companies hosted in the Centre for the production of biological drugs for clinical trials in particular with the pharmaceutical responsibility of Accinov.

 Accinov-Authorization-to-open-a-pharmaceutical-site